Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP257429.RActGNzNCoauqU5fPEAhQT3KvBBUXo8nPCYUleT5rLbEk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP257429.RActGNzNCoauqU5fPEAhQT3KvBBUXo8nPCYUleT5rLbEk130_assertion type Assertion NP257429.RActGNzNCoauqU5fPEAhQT3KvBBUXo8nPCYUleT5rLbEk130_head.
- NP257429.RActGNzNCoauqU5fPEAhQT3KvBBUXo8nPCYUleT5rLbEk130_assertion description "[The prevalence of anti-p22 in 23 HBV carrier HCC patients, 56 patients with non-HCC cancer and 100 healthy blood donors were 4.3, 12.5 and 1.0%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP257429.RActGNzNCoauqU5fPEAhQT3KvBBUXo8nPCYUleT5rLbEk130_provenance.
- NP257429.RActGNzNCoauqU5fPEAhQT3KvBBUXo8nPCYUleT5rLbEk130_assertion evidence source_evidence_literature NP257429.RActGNzNCoauqU5fPEAhQT3KvBBUXo8nPCYUleT5rLbEk130_provenance.
- NP257429.RActGNzNCoauqU5fPEAhQT3KvBBUXo8nPCYUleT5rLbEk130_assertion SIO_000772 1710205 NP257429.RActGNzNCoauqU5fPEAhQT3KvBBUXo8nPCYUleT5rLbEk130_provenance.
- NP257429.RActGNzNCoauqU5fPEAhQT3KvBBUXo8nPCYUleT5rLbEk130_assertion wasDerivedFrom befree-20140225 NP257429.RActGNzNCoauqU5fPEAhQT3KvBBUXo8nPCYUleT5rLbEk130_provenance.
- NP257429.RActGNzNCoauqU5fPEAhQT3KvBBUXo8nPCYUleT5rLbEk130_assertion wasGeneratedBy ECO_0000203 NP257429.RActGNzNCoauqU5fPEAhQT3KvBBUXo8nPCYUleT5rLbEk130_provenance.